Showing results (51-60 of 111) with videos related to

Sort By:
Pageof 12
Blood Advances|December 12, 2022
Nelarabine combination therapy for relapsed or refractory T-cell acute lymphoblastic lymphoma/leukemiaShai Shimony, Yiwen Liu, Yannis K Valtis, et al.
Medrxiv : the Preprint Server for Health Sciences|May 4, 2026
A novel hyperactive <i>BCR::ABL1</i> <sup><i>e6a3</i></sup> variant confers resistance to combined asciminib plus ponatinib therapyValentina Nardi, Joshua Schwieterman, Sekhu Ansari, et al.
The Journal of Molecular Diagnostics : JMD|September 3, 2015
Detection of Dual IDH1 and IDH2 Mutations by Targeted Next-Generation Sequencing in Acute Myeloid Leukemia and Myelodysplastic SyndromesMia Y Platt, Amir T Fathi, Darrell R Borger, et al.
International Journal of Radiation Oncology, Biology, Physics|August 31, 2018
Characteristics and Predictors for Secondary Leukemia and Myelodysplastic Syndrome in Ewing and Osteosarcoma SurvivorsNina N Sanford, Ruoyu Miao, Haotong Wang, et al.
Blood Advances|September 29, 2021
t(4;12)(q12;p13) ETV6-rearranged AML without eosinophilia does not involve PDGFRA: relevance for imatinib insensitivitySarah B Mueller, Paola Dal Cin, Long P Le, et al.
Blood Advances|January 7, 2020
Clinical response to larotrectinib in adult Philadelphia chromosome-like ALL with cryptic ETV6-NTRK3 rearrangementValentina Nardi, Nora Ku, Matthew J Frigault, et al.
Cancer|July 13, 2019
Outcomes for older adults with acute myeloid leukemia after an intensive care unit admissionSamuel D Slavin, Alyssa Fenech, Amanda L Jankowski, et al.
The Lancet. Haematology|March 6, 2017
Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: a cohort studyPavan K Bendapudi, Shelley Hurwitz, Ashley Fry, et al.
Pageof 12